Mingfang Zhao

Efficacy and Safety of KRAS G12C Inhibitor IBI351 Monotherapy in Patients With Advanced NSCLC: Results From a Phase 2 Pivotal Study

Qing Zhou, Xiangjiao Meng, Longhua Sun et al. · Journal of Thoracic Oncology · 2024 · 47 citations · Full text

Medicine, Oncology, Pharmacology +10

Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial

Ziming Li, Xiaomin Dang, Dingzhi Huang et al. · The Lancet Respiratory Medicine · 2024 · 38 citations

Medicine, Genetics, Oncology +6

Effects of combined inoculation of arbuscular mycorrhizal fungi and plant growth-promoting rhizosphere bacteria on seedling growth and rhizosphere microecology

Wanli Zeng, Dan Xiang, Xuemei Li et al. · Frontiers in Microbiology · 2025 · 24 citations · Full text

Agriculture, Microbiology, Plant Sciences +17

A bibliometric analysis of immune-related adverse events in cancer patients and a meta-analysis of immune-related adverse events in patients with hepatocellular carcinoma.

Bengang Wang, X. Hao, Jinshan Yan et al. · PubMed · 2024 · 21 citations · Full text

Medicine, Immunology, Oncology +17

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK-029A in Treatment-Naive Patients With Advanced NSCLC Harboring EGFR Exon 20 Insertion Mutations: A Phase 1 Trial

Jianchun Duan, Lin Wu, Kunyu Yang et al. · Journal of Thoracic Oncology · 2023 · 13 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16